Involvement of Arachidonic Acid Cascade Pathways in lnterleukin-6-Stimulated Corticotropin-Releasing Factor Release in vitro
Abstract
We have demonstrated that centrally administered interleukin-6 (IL-6) stimulates adrenocorticotropin (ACTH) secretion by a direct effect on corticotropin-releasing factor (CRF) release from the hypothalamus. Since metabolites of the arachidonic acid cascade (AAC) have been implicated in mediating actions of cytokines in different tissues and some AAC inhibitors were able to block pyrogenic effects of cytokines and suppress IL-1-induced ACTH secretion, we decided to examine the mechanism of IL-6 action on CRF release in vitro. After a 60-min preincubation in Krebs-Ringer bicarbonate buffer, medial basal hypothalami (MBH) were preincubated for 30 min with dexamethasone (DEX), a phospholipase A2 (PLA2) inhibitor, to block arachidonic acid (AA) formation, or with inhibitors of AA metabolism: a cyclooxygenase inhibitor – indomethacin (IND); a lipoxygenase inhibitor – 5,8,11-eicosatriynoic acid (EΗ), and an epoxygenase inhibitor – clotrimazole (CLO). Then, the medium was discarded and MBH were incubated with medium or the above compounds and/or IL-6 for 30 min, and CRF release into the incubation medium was measured by radioimmunoassay. As reported previously, 10–13 M IL-6 increased CRF release, which was significantly suppressed by DEX in a dose-dependent manner. The suppression was already highly significant at a concentration of 10–11M DEX and became maximal at 10–7 M, at which concentration CRF release was no longer stimulated by IL-6. The response to IL-6 was completely blocked at the highest DEX concentration evaluated (10–5 M). CLO also suppressed IL-6-induced CRF release with a minimal effective dose of 10–9M. Suppression was complete at 10–7 and 10–5 M. IL-6-stimulated CRF release was suppressed significantly only by higher than micromolar concentrations of IND and EΗ. The results suggest that IL-6 stimulates CRF release by the activation of the AAC system and show that PLA2 and epoxygenase inhibitors are far more effective than cyclooxygenase and lipoxygenase inhibitors to block IL-6-stimulated CRF release in vitro. The results suggest an important role for the PLA2 pathway and the epoxygenase pathway in IL-6-induced CRF and ACTH release.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Arachidonate products are involved in IL-6-induction of CRF release.
“Both IL-1 and IL-6 induce PGs in hypothalamic explants (60), and arachidonate products are involved in IL-6-induction of CRF release (61).”
From Interleukin-6 is an afferent signal to the hypothalamo-pituitary-adrenal axis during local inflammation in mice (2003) · cites this paper as [61]
Cited by
Sorted by citations
Regulation of the Hypothalamic-Pituitary-Adrenal Axis by Cytokines: Actions and Mechanisms of Action
TURNBULL, A. V., & RIVIER, C. L. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.1 · Cited by 1,297 · see citing works
Gene expression and function of interleukin I, interleukin 6 and tumor necrosis factor in the brain
Schöbitz, B., de Kloet, E. R., & Holsboer, F. (1994) · Progress in Neurobiology · doi:10.1016/0301-0082(94)90034-5 · Cited by 285 · see citing works
Rivest, S., Lacroix, S., Vallières, L., Nadeau, S., Zhang, J., & Laflamme, N. (2000) · Proceedings of The Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.2000.22304.x · Cited by 270 · see citing works
Perlstein, R. S., Whitnall, M. H., Abrams, J. S., Mougey, E. H., & Neta, R. (1993) · Endocrinology · doi:10.1210/endo.132.3.8382602 · Cited by 257 · see citing works
Rivest, S. (2001) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00064-6 · Cited by 195 · see citing works
McCANN, S. M., KIMURA, M., KARANTH, S., YU, W. H., MASTRONARDI, C. A., & RETTORI, V. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05368.x · Cited by 164 · see citing works
Self-citationAssociations between the neuroendocrine and immune systems
Weigent, D. A., & Blalock, J. E. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.58.2.137 · Cited by 158 · see citing works
Vallières, L., & Rivest, S. (1999) · Endocrinology · doi:10.1210/endo.140.9.6983 · Cited by 157 · see citing works
Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism
Wang, J., & Dunn, A. J. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(98)00016-3 · Cited by 144 · see citing works
Turrin, N. P., & Rivest, S. (2004) · Experimental Biology and Medicine · doi:10.1177/153537020422901003 · Cited by 107 · see citing works
Raber, J., O’Shea, R. D., Bloom, F. E., & Campbell, I. L. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-24-09473.1997 · Cited by 87 · see citing works
Lacroix, S., Vallières, L., & Rivest, S. (1996) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00114-2 · Cited by 88 · see citing works
Buckingham, J. C., Loxley, H. D., Christian, H., & Philip, J. G. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02127-2 · Cited by 80 · see citing works
Buller, K. M. (2001) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2001.03490.x · Cited by 78 · see citing works
Fatty Acids and Brain Peptides
Yehuda, S., Rabinovitz, S., Carasso, R. L., & Mostofsky, D. I. (1998) · Peptides · doi:10.1016/s0196-9781(97)00295-7 · Cited by 75 · see citing works
McCann, S. M., Antunes‐Rodrigues, J., Franci, C. R., Anselmo-Franci, J. A., Karanth, S., & Rettori, V. (2000) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2000001000001 · Cited by 72 · see citing works
“Activation of CRH release can be blocked by the synthetic glucocorticoid dexamethasone (46) and also by blockers of the three pathways of AA metabolism, such as clotrimazole that blocks epoxygenase, which in turn converts AA into epoxides; by indomethacin that inhibits COX and by 5811eicisotrionoic acid that blocks…”
BackgroundInfluentialSelf-citationBarkhudaryan, N., & Dunn, A. J. (1999) · Neurochemical Research · doi:10.1023/a:1020720722209 · Cited by 72 · see citing works
Turnbull, A. V., Prehar, S., Kennedy, A. R., Little, R. A., & Hopkins, S. J. (2003) · Endocrinology · doi:10.1210/en.2002-220964 · Cited by 66 · see citing works
“Both IL-1 and IL-6 induce PGs in hypothalamic explants (60), and arachidonate products are involved in IL-6-induction of CRF release (61).”
BackgroundHuang, S. S. Y., Benskin, J. P., Veldhoen, N., Chandramouli, B., Butler, H., Helbing, C. C., & Cosgrove, J. R. (2016) · Aquatic Toxicology · doi:10.1016/j.aquatox.2016.11.016 · Cited by 67 · see citing works
Vallières, L., Lacroix, S., & Rivest, S. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01500.x · Cited by 60 · see citing works
Rivest, S., Lacroix, S., Vallières, L., et al. (2000) · Proceedings of The Society for Experimental Biology and Medicine · doi:10.1111/j.1525-1373.2000.22304.x · Cited by 60 · see citing works
Kovács, K., & Elenkovt, I. J. (1995) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1995.tb00662.x · Cited by 58 · see citing works
Metabolism modulators in sepsis: The abnormal pituitary response
Maxime, V., Siami, S., & Annane, D. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000279097.67263.52 · Cited by 54 · see citing works
“NO diffuses in the parvocellular cells and induces the generation of both cyclooxygenase and lipoxygenase, which in turn stimulate CRH synthesis (13).”
BackgroundEffect of Peripheral and Central Cytokines on the Hypothalamic‐Pituitary‐Adrenal Axis of the Rata
RIVIER, C. L. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb49926.x · Cited by 53 · see citing works
Aubry, J.-M., Turnbull, A. V., Pozzoli, G., RIVIER, C. L., & Vale, W. W. (1997) · Endocrinology · doi:10.1210/endo.138.4.5050 · Cited by 44 · see citing works
Schlaghecke, R., Beuscher, D., Kornely, E., & Specker, C. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370803 · Cited by 44 · see citing works
Chisari, A. N., Spinedi, E., Voirol, M., et al. (1998) · Endocrinology · doi:10.1210/endo.139.2.5736 · Cited by 44 · see citing works
“been described to mediate both central (7, 37, 38) and pe-”
BackgroundNitric Oxide at the Crossroad of Immunoneuroendocrine Interactions
Rettori, V., Fernández‐Solari, J., Mohn, C. E., Zubilete, M. A. Z., de la Cal, C., Prestifilippo, J. P., & Laurentiis, A. D. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03968.x · Cited by 37 · see citing works
Mechanism of Action of Cytokines to Induce the Pattern of Pituitary Hormone Secretion in Infectiona
McCann, S. M., Lyson, K., Karanth, S., Gimeno, M. A. F., Belova, N., Kamat, A., & Rettori, V. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44697.x · Cited by 30 · see citing works
Self-citationNeuropsychiatric Systemic Lupus Erythematosus
Moore, P. M. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48376.x · Cited by 29 · see citing works
Acyloxyacyl hydrolase modulates depressive-like behaviors through aryl hydrocarbon receptor
Aguiniga, L. M., Yang, W., Yaggie, R. E., Schaeffer, A. J., & Klumpp, D. J. (2019) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00029.2019 · Cited by 26 · see citing works
Lozovaya, N., & Miller, A. (2003) · ChemBioChem · doi:10.1002/cbic.200200492 · Cited by 23 · see citing works
Michl, Beikler, Engelhardt, & Weber (2000) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2000.00423.x · Cited by 24 · see citing works
Role of Cytokines in the Endocrine System
M, S. M., Lyson, K., Karanth, S., et al. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb39644.x · Cited by 21 · see citing works
Self-citationGautron, L., Lafon, P., Tramu, G., & Layé, S. (2003) · Neuroendocrinology · doi:10.1159/000068336 · Cited by 20 · see citing works
Givalois, L., Siaud, P., Mekaouche, M., IXART, G., Malaval, F., ASSENMACHER, I., & Barbanel, G. (1995) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815011 · Cited by 16 · see citing works
Endocrine Aspects of Neuroimmunomodulation: Methods and Overview
McCann, S. M., Milenković, L., González, M. C., et al. (1993) · Methods in neurosciences · doi:10.1016/b978-0-12-185281-8.50017-x · Cited by 17 · see citing works
Self-citationKomori, T. (2003) · Chemical Senses · doi:10.1093/chemse/bjg069 · Cited by 16 · see citing works
“(Navarra et al., 1991; Lyson and McCann, 1992) and the induction of IL-6R in the paraventricular nucleus supports the hypothesis for CRH-mediated stimulation of the HPA axis by IL-6 (Vallières and Rivest, 1999).”
BackgroundRole of Cytokines in the Endocrine System
M, S. M., Lyson, K., Karanth, S., et al. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb23085.x · Cited by 14 · see citing works
Self-citationCytokines and pituitary hormone secretion
McCann, S. M., Kimura, M., Yu, W. H., Mastronardi, C. A., Rettori, V., & Karanth, S. (2001) · Vitamins and hormones · doi:10.1016/s0083-6729(01)63002-4 · Cited by 14 · see citing works
Self-citationPsychoneuroimmunolog Part I: Physiology
Bauer‐Wu, S., & Decker, G. M. (2002) · Clinical journal of oncology nursing · doi:10.1188/02.cjon.167-170 · Cited by 10 · see citing works
PUFA: Mediators for the Nervous, Endocrine, and Immune Systems
Yehuda, S., Rabinovitz, S., & Mostofsky, D. I. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-119-0_23 · Cited by 10 · see citing works
Fatty Acid Regulation of Endocrine Activity
Widmaier, E. P. (1997) · Humana Press eBooks · doi:10.1007/978-1-4757-2582-7_6 · Cited by 9 · see citing works
Tiwari, M. N., Mohan, S., Biala, Y., Shor, O., Benninger, F., & Yaari, Y. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.2475-21.2022 · Cited by 7 · see citing works
Bidirectional Communication Between the Immune and Neuroendocrine Systems
Blalock, J. E., & Weigent, D. A. (1998) · CRC Press eBooks · doi:10.1201/9781420048193.ch12 · Cited by 4 · see citing works
Immune System, Inflammation, and Essential Fatty Acids and Their Metabolites in Cancer
Das, U. N. (2020) · Springer eBooks · doi:10.1007/978-1-0716-0741-1_3 · Cited by 3 · see citing works
Weigent, D. A. (1998) · CRC Press eBooks · doi:10.1201/9781420048193.ch13 · Cited by 3 · see citing works
Endokrines System und perioperative Streßreaktionen
Crozier, T. A. (1995) · Springer eBooks · doi:10.1007/978-3-642-97553-0_50
Bases biológicas de los trastornos del estado de ánimo
Gastó, C. (1998) · Psicología conductual = behavioral psychology: Revista internacional de psicología clínica y de la salud
Effects of Cytokines on the Hypothalamo-Pituitary-Adrenal Axis
Gaillard, R. C. (1994) · Springer eBooks · doi:10.1007/978-1-4757-9104-4_10
Immune Function and Regulation of the Autonomic Nervous System
Rivest, S. (2002) · CRC Press eBooks · doi:10.1201/9780203908891.ch2
Huttenlocher (1997) · doi:10.1002/(sici)1096-9861(19971020)387:2
- Authors
- Lyson, K., & McCann, S. M.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Venue
- Neuroendocrinology
- Publisher
- S. Karger AG
- Published
- 2008-04-07
- Volume
- 55
- Issue
- 6
- Pages
- 708-713
- ISSN
- 0028-3835 (ISSN-L)
- 1423-0194
- OpenAlex
- W2040594794
- Cited by
- 50
- References
- 0
- Citations by year
- 2022: 1 · 2020: 1 · 2019: 1 · 2016: 1
- FWCI
- 0.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroendocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01dk040994-03)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK10073, DK40994)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Pharmacology › Inflammatory mediators and NSAID effects
- Keywords
- arachidonic acid metabolism, interleukin-6, corticotropin-releasing factor, ACTH secretion, hypothalamus, phospholipase A2, cyclooxygenase, lipoxygenase, epoxygenase, clotrimazole, indomethacin, eicosatrienoic acid, dexamethasone, cytokine signaling, neuroendocrine regulation
- MeSH terms
- Animals, Corticotropin-Releasing Hormone, Dexamethasone, Hypothalamus, Male, Radioimmunoassay, Rats, Inbred Strains, Interleukin-6, Arachidonic Acid, Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
